{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:10:05Z","timestamp":1783131005142,"version":"3.54.6"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG061872; RF1AG061729; R01AG085545"],"award-info":[{"award-number":["R01AG061872; RF1AG061729; R01AG085545"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG066546; P30AG013319; P30AG044271; T32AG021890"],"award-info":[{"award-number":["P30AG066546; P30AG013319; P30AG044271; T32AG021890"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG021890"],"award-info":[{"award-number":["T32AG021890"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Methodist Hospital Foundation; The Cure Alzheimer\u2019s Fund; The Owen Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66222-9","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:46:00Z","timestamp":1767966360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sulfatide deficiency-induced astrogliosis and myelin lipid dyshomeostasis are independent of TREM2-mediated microglial activation"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-8770","authenticated-orcid":false,"given":"Sijia","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Mittra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-9542","authenticated-orcid":false,"given":"Sherry G.","family":"Dodds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Dupree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8615-2413","authenticated-orcid":false,"given":"Xianlin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"66222_CR1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.neubiorev.2020.02.012","volume":"112","author":"F Kosel","year":"2020","unstructured":"Kosel, F., Pelley, J. M. S. & Franklin, T. B. Behavioural and psychological symptoms of dementia in mouse models of Alzheimer\u2019s disease-related pathology. Neurosci. Biobehav Rev. 112, 634\u2013647 (2020).","journal-title":"Neurosci. Biobehav Rev."},{"key":"66222_CR2","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z. & Karaman, R. Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25, 5789 (2020).","DOI":"10.3390\/molecules25245789"},{"key":"66222_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.14283\/jpad.2021.15","volume":"8","author":"XX Zhang","year":"2021","unstructured":"Zhang, X. X. et al. The Epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention. J. Prev. Alzheimers Dis. 8, 313\u2013321 (2021).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"66222_CR4","doi-asserted-by":"crossref","unstructured":"Kuo, C. Y., Stachiv, I. & Nikolai, T. Association of late life depression, (Non-) modifiable risk and protective factors with dementia and Alzheimer\u2019s disease: literature review on current evidences, preventive interventions and possible future trends in prevention and treatment of dementia. Int. J. Environ. Res. Public Health 17, 7475 (2020).","DOI":"10.3390\/ijerph17207475"},{"key":"66222_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady, S. E., Rizvi, B., Goldman, J. E. & Brickman, A. M. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol. Commun. 6, 22 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"66222_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1600-0404.1989.tb03886.x","volume":"80","author":"A Wallin","year":"1989","unstructured":"Wallin, A., Gottfries, C. G., Karlsson, I. & Svennerholm, L. Decreased myelin lipids in Alzheimer\u2019s disease and vascular dementia. Acta Neurol. Scand. 80, 319\u2013323 (1989).","journal-title":"Acta Neurol. Scand."},{"key":"66222_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainresbull.2018.05.003","volume":"140","author":"SS Wang","year":"2018","unstructured":"Wang, S. S. et al. Myelin injury in the central nervous system and Alzheimer\u2019s disease. Brain Res. Bull. 140, 162\u2013168 (2018).","journal-title":"Brain Res. Bull."},{"key":"66222_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5114\/aoms.2018.76863","volume":"16","author":"E Papuc","year":"2020","unstructured":"Papuc, E. & Rejdak, K. The role of myelin damage in Alzheimer\u2019s disease pathology. Arch. Med. Sci. 16, 345\u2013351 (2020).","journal-title":"Arch. Med. Sci."},{"key":"66222_CR9","doi-asserted-by":"crossref","unstructured":"Qiu, S. et al. Adult-onset CNS sulfatide deficiency causes sex-dependent metabolic disruption in aging. Int. J. Mol. Sci. 24, 10483 (2023).","DOI":"10.3390\/ijms241310483"},{"key":"66222_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-021-00488-7","volume":"16","author":"S Qiu","year":"2021","unstructured":"Qiu, S. et al. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer\u2019s disease-like neuroinflammation and cognitive impairment. Mol. Neurodegener. 16, 64 (2021).","journal-title":"Mol. Neurodegener."},{"key":"66222_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-025-00803-6","volume":"20","author":"S He","year":"2025","unstructured":"He, S., Xu, Z. & Han, X. Lipidome disruption in Alzheimer\u2019s disease brain: detection, pathological mechanisms, and therapeutic implications. Mol. Neurodegener. 20, 11 (2025).","journal-title":"Mol. Neurodegener."},{"key":"66222_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1089\/ars.2024.0676","volume":"41","author":"Z Xu","year":"2024","unstructured":"Xu, Z., He, S., Begum, M. M. & Han, X. Myelin lipid alterations in neurodegenerative diseases: landscape and pathogenic implications. Antioxid. Redox Signal 41, 1073\u20131099 (2024).","journal-title":"Antioxid. Redox Signal"},{"key":"66222_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","volume":"82","author":"X Han","year":"2002","unstructured":"Han, X. et al. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis. J. Neurochem. 82, 809\u2013818 (2002).","journal-title":"J. Neurochem."},{"key":"66222_CR14","doi-asserted-by":"crossref","unstructured":"Dustin, E. et al. Compromised myelin and axonal molecular organization following adult-onset sulfatide depletion. Biomedicines 11, 1431 (2023).","DOI":"10.3390\/biomedicines11051431"},{"key":"66222_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/jnc.13738","volume":"139","author":"JP Palavicini","year":"2016","unstructured":"Palavicini, J. P. et al. Novel molecular insights into the critical role of sulfatide in myelin maintenance\/function. J. Neurochem. 139, 40\u201354 (2016).","journal-title":"J. Neurochem."},{"key":"66222_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1332","volume":"13","author":"S He","year":"2023","unstructured":"He, S. et al. Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer\u2019s disease. Clin. Transl. Med. 13, e1332 (2023).","journal-title":"Clin. Transl. Med."},{"key":"66222_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/glia.20292","volume":"53","author":"J Marcus","year":"2006","unstructured":"Marcus, J. et al. Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53, 372\u2013381 (2006).","journal-title":"Glia"},{"key":"66222_CR18","doi-asserted-by":"publisher","first-page":"8043","DOI":"10.1074\/jbc.M212340200","volume":"278","author":"X Han","year":"2003","unstructured":"Han, X., Cheng, H., Fryer, J. D., Fagan, A. M. & Holtzman, D. M. Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content. J. Biol. Chem. 278, 8043\u20138051 (2003).","journal-title":"J. Biol. Chem."},{"key":"66222_CR19","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.neurobiolaging.2008.07.020","volume":"31","author":"H Cheng","year":"2010","unstructured":"Cheng, H., Zhou, Y., Holtzman, D. M. & Han, X. Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer\u2019s disease. Neurobiol. Aging 31, 1188\u20131196 (2010).","journal-title":"Neurobiol. Aging"},{"key":"66222_CR20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1210\/er.2011-1049","volume":"33","author":"J Kang","year":"2012","unstructured":"Kang, J. & Rivest, S. Lipid metabolism and neuroinflammation in Alzheimer\u2019s disease: a role for liver X receptors. Endocr. Rev. 33, 715\u2013746 (2012).","journal-title":"Endocr. Rev."},{"key":"66222_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12035-013-8626-0","volume":"50","author":"C Wang","year":"2014","unstructured":"Wang, C., Wang, M., Zhou, Y., Dupree, J. L. & Han, X. Alterations in mouse brain lipidome after disruption of CST gene: a lipidomics study. Mol. Neurobiol. 50, 88\u201396 (2014).","journal-title":"Mol. Neurobiol."},{"key":"66222_CR22","doi-asserted-by":"publisher","first-page":"1125982","DOI":"10.3389\/fphar.2023.1125982","volume":"14","author":"CG McKee","year":"2023","unstructured":"McKee, C. G., Hoffos, M., Vecchiarelli, H. A. & Tremblay, M. E. Microglia: a pharmacological target for the treatment of age-related cognitive decline and Alzheimer\u2019s disease. Front. Pharm. 14, 1125982 (2023).","journal-title":"Front. Pharm."},{"key":"66222_CR23","doi-asserted-by":"publisher","first-page":"1201982","DOI":"10.3389\/fnagi.2023.1201982","volume":"15","author":"J Miao","year":"2023","unstructured":"Miao, J. et al. Microglia in Alzheimer\u2019s disease: pathogenesis, mechanisms, and therapeutic potentials. Front. Aging Neurosci. 15, 1201982 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"66222_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/978-981-19-7376-5_14","volume":"1411","author":"J Kim","year":"2023","unstructured":"Kim, J. & Kim, Y. K. Molecular imaging of neuroinflammation in Alzheimer\u2019s disease and mild cognitive impairment. Adv. Exp. Med. Biol. 1411, 301\u2013326 (2023).","journal-title":"Adv. Exp. Med. Biol."},{"key":"66222_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1100\/tsw.2001.107","volume":"1","author":"A Minagar","year":"2001","unstructured":"Minagar, A. et al. Microglia and astrocytes in neuro-aids, Alzheimers Disease, and Multiple Sclerosis. Sci. World J. 1, 69 (2001).","journal-title":"Sci. World J."},{"key":"66222_CR26","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1046\/j.1471-4159.1996.66062300.x","volume":"66","author":"AC LeBlanc","year":"1996","unstructured":"LeBlanc, A. C., Xue, R. & Gambetti, P. Amyloid precursor protein metabolism in primary cell cultures of neurons, astrocytes, and microglia. J. Neurochem. 66, 2300\u20132310 (1996).","journal-title":"J. Neurochem."},{"key":"66222_CR27","doi-asserted-by":"crossref","unstructured":"Choi, S. B. et al. The molecular mechanisms of neuroinflammation in Alzheimer\u2019s disease, the consequence of neural cell death. Int. J. Mol. Sci. 24, 11757 (2023).","DOI":"10.3390\/ijms241411757"},{"key":"66222_CR28","doi-asserted-by":"publisher","first-page":"e13108","DOI":"10.1111\/bpa.13108","volume":"33","author":"A Fracassi","year":"2023","unstructured":"Fracassi, A. et al. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer\u2019s neuropathology. Brain Pathol. 33, e13108 (2023).","journal-title":"Brain Pathol."},{"key":"66222_CR29","doi-asserted-by":"publisher","first-page":"112773","DOI":"10.1016\/j.celrep.2023.112773","volume":"42","author":"H Gao","year":"2023","unstructured":"Gao, H. et al. Distinct myeloid population phenotypes dependent on TREM2 expression levels shape the pathology of traumatic versus demyelinating CNS disorders. Cell Rep. 42, 112773 (2023).","journal-title":"Cell Rep."},{"key":"66222_CR30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/acschemneuro.5b00313","volume":"7","author":"JD Ulrich","year":"2016","unstructured":"Ulrich, J. D. & Holtzman, D. M. TREM2 function in Alzheimer\u2019s disease and neurodegeneration. ACS Chem. Neurosci. 7, 420\u2013427 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"66222_CR31","doi-asserted-by":"crossref","unstructured":"Cuni-Lopez, C., Stewart, R., Quek, H. & White, A. R. Recent advances in microglia modelling to address translational outcomes in neurodegenerative diseases. Cells 11, 1662 (2022).","DOI":"10.3390\/cells11101662"},{"key":"66222_CR32","doi-asserted-by":"crossref","unstructured":"Wang, S. et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J. Exp. Med. 217, e20200785 (2020).","DOI":"10.1084\/jem.20200785"},{"key":"66222_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-022-00588-y","volume":"17","author":"J Hou","year":"2022","unstructured":"Hou, J., Chen, Y., Grajales-Reyes, G. & Colonna, M. TREM2 dependent and independent functions of microglia in Alzheimer\u2019s disease. Mol. Neurodegener. 17, 84 (2022).","journal-title":"Mol. Neurodegener."},{"key":"66222_CR34","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska, A. et al. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell 173, 1073\u20131081 (2018).","journal-title":"Cell"},{"key":"66222_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667\u2013675 (2016).","journal-title":"J. Exp. Med."},{"key":"66222_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","volume":"94","author":"JD Ulrich","year":"2017","unstructured":"Ulrich, J. D., Ulland, T. K., Colonna, M. & Holtzman, D. M. Elucidating the role of TREM2 in Alzheimer\u2019s disease. Neuron 94, 237\u2013248 (2017).","journal-title":"Neuron"},{"key":"66222_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat. Med. 26, 131\u2013142 (2020).","journal-title":"Nat. Med."},{"key":"66222_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"66222_CR39","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1007\/s00018-021-03830-w","volume":"78","author":"D Zhu","year":"2021","unstructured":"Zhu, D., Montagne, A. & Zhao, Z. Alzheimer\u2019s pathogenic mechanisms and underlying sex difference. Cell Mol. Life Sci. 78, 4907\u20134920 (2021).","journal-title":"Cell Mol. Life Sci."},{"key":"66222_CR40","doi-asserted-by":"crossref","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC bioinformatics 14, 128 (2013)","DOI":"10.1186\/1471-2105-14-128"},{"key":"66222_CR41","doi-asserted-by":"crossref","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic acids research 44, W90-7 (2016)","DOI":"10.1093\/nar\/gkw377"},{"key":"66222_CR42","doi-asserted-by":"crossref","unstructured":"Xie, Z. et al. Gene Set Knowledge Discovery with Enrichr. Current protocols 1, e90 (2021)","DOI":"10.1002\/cpz1.90"},{"key":"66222_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32401-1","volume":"13","author":"WW Luo","year":"2022","unstructured":"Luo, W. W. et al. Transcription-independent regulation of STING activation and innate immune responses by IRF8 in monocytes. Nat. Commun. 13, 4822 (2022).","journal-title":"Nat. Commun."},{"key":"66222_CR44","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1101\/gad.14.9.1156","volume":"14","author":"K Masternak","year":"2000","unstructured":"Masternak, K. et al. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14, 1156\u20131166 (2000).","journal-title":"Genes Dev."},{"key":"66222_CR45","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1091\/mbc.e12-10-0747","volume":"24","author":"S Luanpitpong","year":"2013","unstructured":"Luanpitpong, S. et al. Regulation of apoptosis by Bcl-2 cysteine oxidation in human lung epithelial cells. Mol. Biol. Cell 24, 858\u2013869 (2013).","journal-title":"Mol. Biol. Cell"},{"key":"66222_CR46","doi-asserted-by":"publisher","first-page":"e015862","DOI":"10.1161\/JAHA.120.015862","volume":"9","author":"LJ Du","year":"2020","unstructured":"Du, L. J. et al. Macrophage NCOR1 deficiency ameliorates myocardial infarction and neointimal hyperplasia in mice. J. Am. Heart Assoc. 9, e015862 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"66222_CR47","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. TREM2 drives microglia response to amyloid-beta via SYK-dependent and -independent pathways. Cell 185, 4153\u20134169.e4119 (2022).","journal-title":"Cell"},{"key":"66222_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1194\/jlr.M057869","volume":"57","author":"JH Hong","year":"2016","unstructured":"Hong, J. H. et al. Global changes of phospholipids identified by MALDI imaging mass spectrometry in a mouse model of Alzheimer\u2019s disease. J. Lipid Res. 57, 36\u201345 (2016).","journal-title":"J. Lipid Res."},{"key":"66222_CR49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-022-00542-y","volume":"17","author":"RY Li","year":"2022","unstructured":"Li, R. Y. et al. TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Mol. Neurodegener. 17, 40 (2022).","journal-title":"Mol. Neurodegener."},{"key":"66222_CR50","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/glia.23563","volume":"67","author":"B Linnartz-Gerlach","year":"2019","unstructured":"Linnartz-Gerlach, B. et al. TREM2 triggers microglial density and age-related neuronal loss. Glia 67, 539\u2013550 (2019).","journal-title":"Glia"},{"key":"66222_CR51","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuron.2022.10.022","volume":"111","author":"M Gratuze","year":"2023","unstructured":"Gratuze, M. et al. TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4. Neuron 111, 202\u2013219 e207 (2023).","journal-title":"Neuron"},{"key":"66222_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-021-02372-6","volume":"143","author":"AM Smith","year":"2022","unstructured":"Smith, A. M. et al. Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u2019s pathology. Acta Neuropathol. 143, 75\u201391 (2022).","journal-title":"Acta Neuropathol."},{"key":"66222_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40478-021-01180-z","volume":"9","author":"JS Park","year":"2021","unstructured":"Park, J. S. et al. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 9, 78 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"66222_CR54","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","volume":"36","author":"H Lian","year":"2016","unstructured":"Lian, H. et al. Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s disease. J. Neurosci. 36, 577\u2013589 (2016).","journal-title":"J. Neurosci."},{"key":"66222_CR55","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.it.2020.07.004","volume":"41","author":"MV Sofroniew","year":"2020","unstructured":"Sofroniew, M. V. Astrocyte reactivity: subtypes, states, and functions in CNS innate immunity. Trends Immunol. 41, 758\u2013770 (2020).","journal-title":"Trends Immunol."},{"key":"66222_CR56","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1002\/glia.24423","volume":"71","author":"E Dustin","year":"2023","unstructured":"Dustin, E. et al. Adult-onset depletion of sulfatide leads to axonal degeneration with relative myelin sparing. Glia 71, 2285\u20132303 (2023).","journal-title":"Glia"},{"key":"66222_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0835-4","volume":"14","author":"C Jendresen","year":"2017","unstructured":"Jendresen, C., Arskog, V., Daws, M. R. & Nilsson, L. N. The Alzheimer\u2019s disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway. J. Neuroinflamm. 14, 59 (2017).","journal-title":"J. Neuroinflamm."},{"key":"66222_CR58","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/CM9.0000000000002167","volume":"136","author":"S Lyu","year":"2023","unstructured":"Lyu, S., Lan, Z. & Li, C. The triggering receptor expressed on myeloid cells 2-apolipoprotein E signaling pathway in diseases. Chin. Med. J. 136, 1291\u20131299 (2023).","journal-title":"Chin. Med. J."},{"key":"66222_CR59","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160, 1061\u20131071 (2015).","journal-title":"Cell"},{"key":"66222_CR60","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3233\/JAD-121864","volume":"34","author":"BN Dugger","year":"2013","unstructured":"Dugger, B. N. et al. The distribution of phosphorylated tau in spinal cords of Alzheimer\u2019s disease and non-demented individuals. J. Alzheimers Dis. 34, 529\u2013536 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"66222_CR61","doi-asserted-by":"crossref","unstructured":"Xie, Q., Zhao, W. J., Ou, G. Y. & Xue, W. K. An overview of experimental and clinical spinal cord findings in Alzheimer\u2019s disease. Brain Sci. 9, 168 (2019).","DOI":"10.3390\/brainsci9070168"},{"key":"66222_CR62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1471-4159.2006.04342.x","volume":"101","author":"H Cheng","year":"2007","unstructured":"Cheng, H., Jiang, X. & Han, X. Alterations in lipid homeostasis of mouse dorsal root ganglia induced by apolipoprotein E deficiency: a shotgun lipidomics study. J. Neurochem. 101, 57\u201376 (2007).","journal-title":"J. Neurochem."},{"key":"66222_CR63","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1021\/ac900241u","volume":"81","author":"K Yang","year":"2009","unstructured":"Yang, K., Cheng, H., Gross, R. W. & Han, X. Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. Anal. Chem. 81, 4356\u20134368 (2009).","journal-title":"Anal. Chem."},{"key":"66222_CR64","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/mas.21492","volume":"36","author":"M Wang","year":"2017","unstructured":"Wang, M., Wang, C. & Han, X. Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry-What, how and why? Mass Spectrom. Rev. 36, 693\u2013714 (2017).","journal-title":"Mass Spectrom. Rev."},{"key":"66222_CR65","doi-asserted-by":"publisher","first-page":"W147","DOI":"10.1093\/nar\/gkw419","volume":"44","author":"S Babicki","year":"2016","unstructured":"Babicki, S. et al. Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res. 44, W147\u2013W153 (2016).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66222-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66222-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66222-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T19:02:51Z","timestamp":1768330971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66222-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66222"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66222-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}